Skip to main content
SpringerLink
Log in

Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves Dermal Collagen Arrangements

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

Background:

Collagen organization within tissues has a critical role in wound regeneration. Collagen fibril diameter, arrangements and maturity between connective tissue growth factor (CTGF) small interfering RNA (siRNA) and mismatch scrambled siRNA-treated wound were compared to evaluate the efficacy of CTGF siRNA as a future implement for scar preventive medicine.

Methods:

Nanocomplexes of CTGF small interfering RNA (CTGF siRNA) with cell penetrating peptides (KALA and MPG∆NLS) were formulated and their effects on CTGF downregulation, collagen fibril diameter and arrangement were investigated. Various ratios of CTGF siRNA and peptide complexes were prepared and down-regulation were evaluated by immunoblot analysis. Control and CTGF siRNA modified cells-populated collagen lattices were prepared and rates of contraction measured. Collagen organization in rabbit ear 8 mm biopsy punch wound at 1 day to 8 wks post injury time were investigated by transmission electron microscopy and histology was investigated with Olympus System and TS-Auto software.

Conclusion:

CTGF expression was down-regulated to 40% of control by CTGF siRNA/KALA (1:24) complexes (p < 0.01) and collagen lattice contraction was inhibited. However, down-regulated of CTGF by CTGF siRNA/MPG∆NLS complexes was not statistically significant. CTGF KALA-treated wound appeared with well formed-basket weave pattern of collagen fibrils with mean diameter of 128 ± 22 nm (n = 821). Mismatch siRNA/KALA-treated wound showed a high frequency of parallel small diameter fibrils (mean 90 ± 20 nm, n = 563).

Conclusion:

Controlling over-expression of CTGF by peptide-mediated siRNA delivery could improve the collagen orientation and tissue remodeling in full thickness rabbit ear wound.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Block L, Gosain A, King TW. Emerging therapies for scar prevention. Adv Wound Care (New Rochelle). 2015;4:607–14.

    Article  Google Scholar 

  2. Brown BC, Mckenna SP, Siddhi K, McGrouthe DA, Bayat A. The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg. 2008;61:1049–58.

    Article  CAS  Google Scholar 

  3. Young VL, Hutchison J. Insights into patient and clinician concerns about scar appearance: semi quantitative structured surveys. Plast Reconstr Surg. 2009;124:256–65.

    Article  CAS  Google Scholar 

  4. Cross KJ, Mustoe TA. Growth factors in wound healing. Surg Clin North Am. 2003;83:531–45.

    Article  Google Scholar 

  5. Reish RG, Eriksson E. Scars: a review of emerging and currently available therapies. Plast Reconstr Surg. 2008;122:1068–78.

    Article  CAS  Google Scholar 

  6. Campaner AB, Ferreira LM, Gragnani A, Bruder JM, Cusick JL, Morgan JR. Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol. 2006;126:1168–76.

    Article  CAS  Google Scholar 

  7. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy. Matrix Biol. 2002;21:473–82.

    Article  CAS  Google Scholar 

  8. Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, et al. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. J Cell Physiol. 2005;203:447–56.

    Article  CAS  Google Scholar 

  9. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendors GR. Stimulation of fibroblast cell growth, matrix production and granulation tissue formation by CTGF. J Invest Dermatol. 1996;107:404–11.

    Article  CAS  Google Scholar 

  10. Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, et al. Selective expression of CTGF in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 2010;62:1523–32.

  11. Leask A, Holmes A, Abraham DJ. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep. 2002;4:136–42.

    Article  Google Scholar 

  12. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, et al. Inhibition of CTGF by siRNA prevents liver fibrosis in rats. J Gene Med. 2006;8:889–900.

    Article  Google Scholar 

  13. Nishio N, Ito S, Suzuki H, Isobe K. Antibodies to wounded tissue enhance cutaneous wound healing. Immunology. 2009;128:369–80.

    Article  CAS  Google Scholar 

  14. Sisco M, Kryger ZB, O’Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, et al. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen. 2008;16:661–73.

    Article  Google Scholar 

  15. Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, Dean NM, et al. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol. 2003;163:2043–52.

    Article  CAS  Google Scholar 

  16. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8:129–38.

    Article  CAS  Google Scholar 

  17. Eguchi A, Dowdy SF. siRNA delivery using peptide transduction domains. Trends Pharmacol Sci. 2009;30:341–5.

    Article  CAS  Google Scholar 

  18. Wang JF, Olson ME, Ma L, Brigstock DR, Hart DA. Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts. Wound Repair Regen. 2004;12:205–16.

    Article  Google Scholar 

  19. Berthod F, Germain L, Li H, Xu W, Damour O, Auger FA. Collagen fibril network and elastic system remodeling in a reconstructed skin transplanted on nude mice. Matrix Biol. 2001;20:463–73.

    Article  CAS  Google Scholar 

  20. White JF, Werkmeister JA, Darby IA, Bisucci T, Birk DE, Ramshaw JA. Collagen fibril formation in a wound healing model. J Struct Biol. 2002;137:23–30.

    Article  CAS  Google Scholar 

  21. Moon H, Yong H, Lee AR. Optimum scratch assay condition to evaluate connective tissue growth factor for anti-scar therapy. Arch Pharm Res. 2012;35:383–8.

    Article  CAS  Google Scholar 

  22. Kim SC, Cho Lee A. Preparation of reproducible and responsive scar model and histology analysis. J Pharm Investig. 2010;40:45–9.

    Article  Google Scholar 

  23. Reid RR, Mogford JE, Butt R, deGiorgio-Miller A, Mustoe TA. Inhibition of procollagen C-proteinase reduces scar hyperthrophy in a rabbit model of cutaneous scarring. Wound Repair Regen. 2006;14:138–41.

    Article  Google Scholar 

  24. Wyman TB, Nicol F, Zelphati O, Scaria PV, Plank C, Szoka FC Jr. Design, synthesis and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry. 1997;36:3008–17.

    Article  CAS  Google Scholar 

  25. Crombez L, Aldrian-Herrada G, Konate K, Nguyen QN, McMaster GK, Brasseur R, Heitz F, et al. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther. 2009;17:95–103.

    Article  CAS  Google Scholar 

  26. Mok H, Park TG. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers. 2007;89:881–8.

    Article  Google Scholar 

  27. Lee SH, Kim SH, Park TG. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Biochem Biophys Res Commun. 2007;357:511–6.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the research grant from 2017 Duksung Women’s University. We thank to Ms. Youli Lee for her excellent technical assistance in quantitative analysis of collagen morphology. We thank to Prof. KC Park at Dermatology Department, School of Medicine, Seoul National University for his valuable discussion and donation of primary human fibroblasts.

Author information

Authors and Affiliations

  1. College of Pharmacy, Duksung Women’s University, 33 Samyang-ro 144-gil, Dobong-gu, Seoul, 01369, Republic of Korea

    Ae-Ri Cho Lee & Inhae Woo

Authors
  1. Ae-Ri Cho Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Inhae Woo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ae-Ri Cho Lee.

Ethics declarations

Conflicts of interest

The authors have no financial conflicts of interest.

Ethical statement

The animal study was performed after receiving approval of the Institutional Animal Care and Use Committee in Duksung Women’s University (IACUC no. 2018-003-009).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cho Lee, AR., Woo, I. Local Silencing of Connective Tissue Growth Factor by siRNA/Peptide Improves Dermal Collagen Arrangements. Tissue Eng Regen Med 15, 711–719 (2018). https://doi.org/10.1007/s13770-018-0166-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-018-0166-2

Keywords

Search

Navigation